CCR5 and HIV infectious disease: Thus, the ability of R5 Envs to engage certain alternative coreceptors, albeit in cell lines, may also reflect an altered use of CCR5 that is selected for during progressive C-HIV infection and which may contribute to C-HIV pathogenicity.